The proof is in the pudding: patient engagement in studying cannabidiol in mild cognitive impairment
Abstract Background Patient engagement (PE) in clinical trials has gained importance yet remains uncommon, particularly in patients with mild cognitive impairment (MCI), a critical precursor to Alzheimer’s disease (AD). Cannabidiol (CBD) shows potential in slowing MCI progression due to its neuropro...
Những tác giả chính: | Antonia Keck, Julia-Sophia Scheuermann, Petra Scheerbaum, Elmar Graessel, Kirsten R. Müller-Vahl |
---|---|
Định dạng: | Bài viết |
Ngôn ngữ: | English |
Được phát hành: |
BMC
2025-01-01
|
Loạt: | BMC Complementary Medicine and Therapies |
Những chủ đề: | |
Truy cập trực tuyến: | https://doi.org/10.1186/s12906-025-04753-w |
Những quyển sách tương tự
-
Disposition of Cannabidiol Metabolites in Serum and Urine from Healthy Individuals Treated with Pharmaceutical Preparations of Medical Cannabis
Bằng: Ana Pilar Pérez-Acevedo, et al.
Được phát hành: (2020-12-01) -
Individualised computerised cognitive training (iCCT) for community-dwelling people with mild cognitive impairment (MCI): results on cognition in the 6-month intervention period of a randomised controlled trial (MCI-CCT study)
Bằng: Elmar Graessel, et al.
Được phát hành: (2024-10-01) -
3D Printed Bigel: A Novel Delivery System for Cannabidiol-Rich Hemp Extract
Bằng: Anna Gościniak, et al.
Được phát hành: (2024-11-01) -
Cannabis Contaminants Limit Pharmacological Use of Cannabidiol
Bằng: Zackary Montoya, et al.
Được phát hành: (2020-09-01) -
El cannabidiol y sus indicaciones en psiquiatría
Bằng: Juan Fernando Muñoz Ramírez
Được phát hành: (2021-03-01)